Stay updated on TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial page.

Latest updates to the TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThis change adds a new revision tag 'Revision: v3.3.2' and removes 'Revision: v3.2.0' from the page footer. No study content, eligibility criteria, or results are altered.SummaryDifference0.1%

- Check28 days agoChange DetectedEstimated timestamps were added to Study Record Dates for Results First Posted and Last Update Posted (2025-11-07). The government funding lapse notice previously displayed was removed.SummaryDifference0.6%

- Check35 days agoChange DetectedResults have been posted (Results First Posted 2025-11-10) with updated efficacy and safety outcomes (ORR, DCR, DOR, OS, PFS) and RECIST-based timeframes, and the study documents include the Protocol and SAP PDF; Megan Daly, MD is now listed in the sponsor/investigator section.SummaryDifference2%

- Check42 days agoChange DetectedThe study page appears the same in content; only minor formatting adjustments are visible, and all major sections (Overview, Eligibility Criteria, Study Plan, and Locations) remain unchanged.SummaryDifference0.3%

- Check71 days agoChange DetectedAdded a government-operating-status notice and a version upgrade to v3.2.0; removed the previous version v3.1.0. The page now informs users about potential delays and funding impacts and directs to official sources for status.SummaryDifference3%

- Check78 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content visible on the page.SummaryDifference0.1%

Stay in the know with updates to TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TG4010 & Nivolumab Combo in Lung Cancer Clinical Trial page.